close

Creative Medical Technology Holdings, Inc. - Common Stock (NQ:CELZ)

3.132 -0.138 (-4.21%)
Streaming Delayed Price Updated: 3:18 PM EDT, Oct 31, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 112,234
Open 3.300
Bid (Size) 3.120 (50)
Ask (Size) 3.140 (2)
Prev. Close 3.270
Today's Range 3.050 - 3.366
52wk Range 1.690 - 6.900
Shares Outstanding 2,580,532
Dividend Yield N/A

Performance

YTD
+35.6%
+35.6%
1 Month
-5.9%
-5.9%
3 Month
+12.7%
+12.7%
6 Month
+57.4%
+57.4%
1 Year
-25.9%
-25.9%

More News

Read More

Frequently Asked Questions

Is Creative Medical Technology Holdings, Inc. - Common Stock publicly traded?
Yes, Creative Medical Technology Holdings, Inc. - Common Stock is publicly traded.
What exchange does Creative Medical Technology Holdings, Inc. - Common Stock trade on?
Creative Medical Technology Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Creative Medical Technology Holdings, Inc. - Common Stock?
The ticker symbol for Creative Medical Technology Holdings, Inc. - Common Stock is CELZ on the Nasdaq Stock Market
What is the current price of Creative Medical Technology Holdings, Inc. - Common Stock?
The current price of Creative Medical Technology Holdings, Inc. - Common Stock is 3.132
When was Creative Medical Technology Holdings, Inc. - Common Stock last traded?
The last trade of Creative Medical Technology Holdings, Inc. - Common Stock was at 10/31/25 03:18 PM ET
What is the market capitalization of Creative Medical Technology Holdings, Inc. - Common Stock?
The market capitalization of Creative Medical Technology Holdings, Inc. - Common Stock is 8.08M
How many shares of Creative Medical Technology Holdings, Inc. - Common Stock are outstanding?
Creative Medical Technology Holdings, Inc. - Common Stock has 8M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today